Who makes [14C]-BLU-5937?

[14C]-BLU-5937 is developed by Bellus Health Inc. - a GSK company.

Last reviewed 2026-04-19 · How we verify

[14C]-BLU-5937

Bellus Health Inc. - a GSK company · Phase 1 active Small molecule

At a glance

Generic name	[14C]-BLU-5937
Sponsor	Bellus Health Inc. - a GSK company
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C]-BLU-5937 CI brief — competitive landscape report
[14C]-BLU-5937 updates RSS · CI watch RSS
Bellus Health Inc. - a GSK company portfolio CI